{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:11:33Z","timestamp":1791432693719,"version":"4.3.3"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Orthop Relat Res"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Unified Periprosthetic Joint Infection (PJI) Criteria were developed and endorsed by the European Society of Clinical Microbiology and Infectious Diseases, the European Bone and Joint Infection Society, the Infectious Diseases Society of America, and the Musculoskeletal Infection Society and formally presented at the 2025 International Consensus Meeting. These criteria recommended that synovial fluid white blood cells (WBC) &gt; 3000 cells\/\u00b5L or polymorphonuclear cells (PMN) &gt; 75% each should be considered individually sufficient to confirm a diagnosis of PJI as standalone rule-in tests, stating specificity of &gt; 95%. These thresholds and performance align with a 2025 meta-analysis published on behalf of the Unified PJI Definition Task Force, reporting specificities of 98.5% and 97.8%, respectively. Because such near-perfect specificities conflict with prior meta-analyses and known causes of false-positive leukocyte testing, independent validation of the supporting evidence is warranted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Questions\/purposes<\/jats:title>\n                    <jats:p>(1) Is the 2025 meta-analysis published on behalf of the Unified PJI Definition Task Force methodologically rigorous and reproducible under independent appraisal and audit? (2) Do WBC count and PMN percentage demonstrate sufficient and generalizable rule-in performance for PJI?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An independent consortium with expertise in PJI diagnostics, epidemiology, and biostatistics conducted a formal methodological reappraisal of the 2025 meta-analysis. To address the first study question, the 2025 meta-analysis, all 74 primary studies, and the original source data files provided by that study\u2019s authors were assessed. After reproducing the original results of the 2025 meta-analysis to confirm understanding of data files and workflow, two independent reviewers used A Measurement Tool to Assess Systematic Reviews (AMSTAR-2) to assess quality, and then a methodological audit was performed using the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Limitations were graded by consensus as critical, major, or minor, with critical limitations independently verified by three statisticians and two clinicians. To address our second study question, a reanalysis of the same corpus of 74 studies was performed using a hierarchical bivariate random-effects model, restricted to studies with predetermined thresholds. A standalone rule-in test is one in which a positive result alone is sufficient to establish the diagnosis of PJI, and its performance is most appropriately assessed using positive predictive value (PPV), which directly reflects the probability that a positive result represents true PJI. Sufficient rule-in performance was pragmatically defined as a PPV of &gt; 90% across clinically plausible prevalence rates. Sufficiently generalizable performance was defined as demonstrable consistency across institutions, assessed through between-study heterogeneity of specificity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      For the first study question, AMSTAR-2 assessment rated the 2025 meta-analysis as critically low overall confidence, reflecting weaknesses in multiple domains. Three critical limitations were identified during audit: (1) a data integrity discrepancy in the software input table used for the 2025 meta-analysis, in which false-positive counts were placed in the false-negative column and false-negative counts were placed in the false-positive column for all studies, rendering downstream results unreliable; (2) an outcome-dependent (self-fulfilling) threshold-selection approach that included only studies already reporting &gt; 95% sensitivity or specificity, yielding results that were mathematically constrained to meet the 95% performance criteria, followed by derivation of thresholds using unweighted medians rather than meta-analytic techniques; and (3) presentation of pooled estimates and clinical threshold recommendations despite acknowledgment of markedly high heterogeneity (I\n                      <jats:sup>2<\/jats:sup>\n                      statistic 88.3% to 99.3%). Major limitations included unit-of-analysis errors, use of specificity alone (rather than PPV) to define rule-in performance, unaddressed incorporation bias, and reliance on data-driven (Youden index) threshold selection. Regarding our second study question, in a reanalysis of the same 74 source studies, we found that WBC count and PMN percentage did not demonstrate sufficient or generalizable rule-in performance for PJI. Specifically, the heterogeneity for specificity remained high (I\n                      <jats:sup>2<\/jats:sup>\n                      = 85% for WBC and I\n                      <jats:sup>2<\/jats:sup>\n                      = 93% for PMN), reflecting considerable between-study variability. Summary specificity was 90% (95% confidence interval [CI] 86% to 92%) for WBC and 92% (95% CI 87% to 96%) for PMN. Resulting PPVs were low across clinically plausible disease prevalence rates, with point estimates of 67% (95% CI 61% to 74%) and 73% (95% CI 63% to 87%), respectively, at 20% PJI prevalence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Critical data integrity discrepancies and methodological limitations substantially undermine the reliability of the 2025 meta-analysis published on behalf of the Unified PJI Definition Task Force. Reanalysis of the same evidence base using recommended meta-analytic methods characterizes WBC count and PMN percentage as poor standalone rule-in tests for PJI for two main reasons: (1) the high heterogeneity of specificity for both WBC count and PMN percentage undermines the generalizability of these tests across institutions and precludes the establishment of universal thresholds, and (2) PPVs at clinically reasonable prevalence rates were low (67% to 73%) for standalone rule-in test usage, meaning that roughly 1 in 3 positive results would likely be a false-positive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Relevance<\/jats:title>\n                    <jats:p>We recommend that surgeons not use synovial fluid WBC count or PMN percentage thresholds as standalone rule-in criteria for PJI. Instead, these tests should be interpreted as supportive findings within a multimodal diagnostic framework, particularly when results are discordant with clinical findings, cultures, histology, serum markers, or other synovial tests. Professional organizations and regulatory bodies should reconsider recommending WBC count or PMN percentage as standalone rule-in tests for PJI until methodologically robust evidence demonstrates reproducible thresholds with sufficiently high PPVs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/corr.0000000000004002","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:00:10Z","timestamp":1780495210000},"page":"1888-1902","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Synovial Fluid Leukocyte Count and Differential Are Poor Standalone Rule-in Tests for Periprosthetic Joint Infection: Results of a Methodological Audit and Reanalysis of the 2025 Meta-analysis Underpinning the Unified Periprosthetic Joint Infection Criteria"],"prefix":"10.1097","volume":"484","author":[{"given":"Ashwaghosha","family":"Parthasarathi","sequence":"first","affiliation":[{"name":"Rutgers RWJBarnabas Center for Climate, Health and Healthcare, New Brunswick, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soko","family":"Setoguchi","sequence":"additional","affiliation":[{"name":"Rutgers RWJBarnabas Center for Climate, Health and Healthcare, New Brunswick, NJ, USA"},{"name":"Division of Cardiology, Department of Medicine, Robert Wood Johnson Medical School, New Brunswick, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrick K.","family":"DeConti","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kupchak","sequence":"additional","affiliation":[{"name":"Independent Consultant (Statistics), Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8932-021X","authenticated-orcid":false,"given":"Patrick","family":"Donnelly","sequence":"additional","affiliation":[{"name":"American Academy of Orthopaedic Surgeons, Rosemont, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Kardos","sequence":"additional","affiliation":[{"name":"Independent Consultant (Diagnostics), Bethlehem, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex C.","family":"McLaren","sequence":"additional","affiliation":[{"name":"Orthopaedic Surgery, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yale A.","family":"Fillingham","sequence":"additional","affiliation":[{"name":"Orthopaedic Surgery, The Rothman Orthopaedic Institute, Thomas Jefferson University, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett R.","family":"Levine","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Medstar Georgetown University, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2559-8809","authenticated-orcid":false,"given":"Carl","family":"Deirmengian","sequence":"additional","affiliation":[{"name":"Orthopaedic Surgery, The Rothman Orthopaedic Institute, Thomas Jefferson University, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"R1-20260929","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.arth.2024.02.064","article-title":"Synovial calprotectin is superior to synovial leukocyte count in excluding chronic periprosthetic joint infections, a retrospective cohort study","volume":"39","author":"Alkadhem","year":"2024","journal-title":"J Arthroplasty"},{"key":"R2-20260929","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2106\/JBJS.18.00632","article-title":"Diagnostic accuracy of serum, synovial, and tissue testing for chronic periprosthetic joint infection after hip and knee replacements: a systematic review","volume":"101","author":"Carli","year":"2019","journal-title":"J Bone Joint Surg Am."},{"key":"R3-20260929","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2106\/JBJS.N.01249","article-title":"Evaluation of the role for synovial aspiration in the diagnosis of aseptic loosening after total knee arthroplasty","volume":"97","author":"Chalmers","year":"2015","journal-title":"J Bone Joint Surg Am."},{"key":"R4-20260929","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00264-018-3865-3","article-title":"The role of synovial fluid analysis in the detection of periprosthetic hip and knee infections: a systematic review and meta-analysis","volume":"42","author":"De Fine","year":"2018","journal-title":"Int Orthop"},{"key":"R5-20260929","doi-asserted-by":"crossref","first-page":"2058738418806072","DOI":"10.1177\/2058738418806072","article-title":"Alpha defensin, leukocyte esterase, C-reactive protein, and leukocyte count in synovial fluid for pre-operative diagnosis of periprosthetic infection","volume":"32","author":"De Vecchi","year":"2018","journal-title":"Int J Immunopathol Pharmacol."},{"key":"R7-20260929","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1097\/CORR.0000000000001188","article-title":"Synovial fluid aspirates diluted with saline or blood reduce the sensitivity of traditional and contemporary synovial fluid biomarkers","volume":"478","author":"Deirmengian","year":"2020","journal-title":"Clin Orthop Relat Res"},{"key":"R8-20260929","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2106\/JBJS.20.00749","article-title":"Validation of the alpha defensin lateral flow test for periprosthetic joint infection","volume":"103","author":"Deirmengian","year":"2021","journal-title":"J Bone Joint Surg Am"},{"key":"R9-20260929","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1016\/j.arth.2020.01.060","article-title":"False-positive automated synovial fluid white blood cell counting is a concern for both hip and knee arthroplasty aspirates","volume":"35","author":"Deirmengian","year":"2020","journal-title":"J Arthroplasty"},{"key":"R10-20260929","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00402-020-03427-1","article-title":"Synovial neutrophilic gelatinase-associated lipocalin in the diagnosis of periprosthetic joint infection after total knee arthroplasty","volume":"140","author":"Dijkman","year":"2020","journal-title":"Arch Orthop Trauma Surg"},{"key":"R11-20260929","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5194\/jbji-8-109-2023","article-title":"Simple and inexpensive synovial fluid biomarkers for the diagnosis of prosthetic joint infection according to the new EBJIS definition","volume":"8","author":"Diniz","year":"2023","journal-title":"J Bone Jt Infect"},{"key":"R13-20260929","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.arth.2007.08.016","article-title":"Determining \u201ctrue\u201d leukocytosis in bloody joint aspiration","volume":"23","author":"Ghanem","year":"2008","journal-title":"J Arthroplasty"},{"key":"R14-20260929","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.arth.2021.12.020","article-title":"Synovial-based tests outperform serum markers to rule out infection in total knee arthroplasty and total hip arthroplasty: a systematic review and meta-analysis","volume":"37","author":"Goud","year":"2022","journal-title":"J Arthroplasty"},{"issue":"102-b Suppl A","key":"R15-20260929","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1302\/0301-620X.102B6.BJJ-2019-1679.R1","article-title":"Saline lavage after a \u201cdry tap\u201d","author":"Heckmann","year":"2020","journal-title":"Bone Joint J"},{"key":"R16-20260929","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.arth.2023.05.095","article-title":"Refining the role of routine synovial alpha-defensin in periprosthetic joint infection following total knee arthroplasty: an analysis of limitations","volume":"38","author":"Heckmann","year":"2023","journal-title":"J Arthroplasty"},{"key":"R18-20260929","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jama.1994.03510330081039","article-title":"Users\u2019 guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group","volume":"271","author":"Jaeschke","year":"1994","journal-title":"JAMA"},{"key":"R19-20260929","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00402-024-05652-4","article-title":"Assessing the reliability of automated cell count analysis of synovial fluid in the setting of revision total knee arthroplasty","volume":"145","author":"Karlidag","year":"2024","journal-title":"Arch Orthop Trauma Surg"},{"key":"R20-20260929","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2106\/JBJS.17.00123","article-title":"Synovial fluid biomarkers for the diagnosis of periprosthetic joint infection: a systematic review and meta-analysis","volume":"99","author":"Lee","year":"2017","journal-title":"J Bone Joint Surg Am"},{"key":"R21-20260929","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0883-5403(03)00448-0","article-title":"The value of white blood cell counts before revision total knee arthroplasty","volume":"18","author":"Mason","year":"2003","journal-title":"J Arthroplasty"},{"key":"R22-20260929","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1302\/0301-620X.103B1.BJJ-2020-1381.R1","article-title":"The EBJIS definition of periprosthetic joint infection","volume":"103-b","author":"McNally","year":"2021","journal-title":"Bone Joint J"},{"key":"R23-20260929","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R24-20260929","doi-asserted-by":"crossref","first-page":"167","DOI":"10.7150\/jbji.34854","article-title":"Factors to consider when assessing the diagnostic accuracy of synovial leukocyte count in periprosthetic joint infection","volume":"4","author":"Ottink","year":"2019","journal-title":"J Bone Jt Infect"},{"key":"R25-20260929","first-page":"e51036","article-title":"Achieving high accuracy in predicting the probability of periprosthetic joint infection from synovial fluid in patients undergoing hip or knee arthroplasty: the development and validation of a multivariable machine learning algorithm","volume":"15","author":"Paranjape","year":"2023","journal-title":"Cureus"},{"key":"R26-20260929","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.arth.2014.03.009","article-title":"Definition of periprosthetic joint infection","volume":"29","author":"Parvizi","year":"2014","journal-title":"J Arthroplasty"},{"key":"R27-20260929","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1007\/s11999-011-2102-9","article-title":"New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society","volume":"469","author":"Parvizi","year":"2011","journal-title":"Clin Orthop Relat Res"},{"key":"R28-20260929","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.arth.2020.12.005","article-title":"Projected economic burden of periprosthetic joint infection of the hip and knee in the United States","volume":"36","author":"Premkumar","year":"2021","journal-title":"J Arthroplasty"},{"key":"R29-20260929","doi-asserted-by":"crossref","first-page":"e84751","DOI":"10.1371\/journal.pone.0084751","article-title":"Evaluation of white cell count and differential in synovial fluid for diagnosing infections after total hip or knee arthroplasty","volume":"9","author":"Qu","year":"2014","journal-title":"PLoS One."},{"key":"R31-20260929","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"R32-20260929","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/sim.942","article-title":"A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations","volume":"20","author":"Rutter","year":"2001","journal-title":"Stat Med."},{"key":"R33-20260929","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5194\/jbji-10-165-2025","article-title":"Differential synovial fluid white blood cell count for the diagnosis of chronic peri-prosthetic joint infection - a systematic review and meta-analysis","volume":"10","author":"Sabater-Martos","year":"2025","journal-title":"J Bone Jt Infect"},{"key":"R34-20260929","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1016\/j.arth.2017.06.005","article-title":"Diagnosing periprosthetic joint infection: and the winner is?","volume":"32","author":"Shahi","year":"2017","journal-title":"J Arthroplasty"},{"key":"R35-20260929","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"R36-20260929","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.1016\/j.arth.2018.09.045","article-title":"Hip and knee section, what is the definition of a periprosthetic joint infection (PJI) of the knee and the hip? Can the same criteria be used for both joints? Proceedings of International Consensus on Orthopedic Infections","volume":"34","author":"Shohat","year":"2019","journal-title":"J Arthroplasty"},{"key":"R37-20260929","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1302\/0301-620X.99B3.BJJ-2016-0684.R1","article-title":"Improving the accuracy of synovial fluid analysis in the diagnosis of prosthetic joint infection with simple and inexpensive biomarkers: C-reactive protein and adenosine deaminase","volume":"99-b","author":"Sousa","year":"2017","journal-title":"Bone Joint J"},{"key":"R38-20260929","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1053\/j.jfas.2019.03.006","article-title":"The impact of \u03b1-defensin test in diagnosing periprosthetic infection after total ankle arthroplasty","volume":"58","author":"Thiesen","year":"2019","journal-title":"J Foot Ankle Surg"},{"key":"R39-20260929","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"R41-20260929","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2288-6-31","article-title":"Meta-DiSc: a software for meta-analysis of test accuracy data","volume":"6","author":"Zamora","year":"2006","journal-title":"BMC Med Res Methodol"}],"container-title":["Clinical Orthopaedics &amp; Related Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CORR.0000000000004002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:03:42Z","timestamp":1790694222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CORR.0000000000004002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/corr.0000000000004002","relation":{},"ISSN":["0009-921X","1528-1132"],"issn-type":[{"value":"0009-921X","type":"print"},{"value":"1528-1132","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"2026-01-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}